Coming of age for CDK 4/6 inhibitors: Welcome and interactive session

Share :
Sorry, this item is currently unavailable.
Published: 26 Oct 2016
Views: 3236
Dr Giuesppe Curigliano - European Institute of Oncology, Milan, Italy

Dr Curigliano opens the 'Coming of age for CDK 4/6 inhibitors' symposium with an interactive session, at ESMO 2016.

Supported by a grant from Pfizer Inc.